Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
Recruiting · NCT06540547 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Pittsburgh
View the official record on ClinicalTrials.gov →Interventions studied
MomMA Intervention
What this trial is about
The study will develop and test a behavioral program for pregnant individuals with Attention-Deficit/Hyperactivity Disorder (ADHD). This behavioral program will include skills for managing ADHD and related symptoms during pregnancy and after delivery and will be taught by a behavioral therapist in OB care settings.
Who can take part
Age range
18 Years to 55 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- (1) meet full DSM-5 criteria for ADHD
- (2) are between 20- and 32-weeks of gestation
- (3) speak English
- (4) will deliver at the University of Pittsburgh Medical Center (UPMC) Magee Women's Hospital (MWH)
Exclusion criteria
- (1) active substance use disorder
- (2) intellectual disability
- (3) other severe mental illness, including bipolar disorder, psychosis, and major depressive disorder with suicidal ideation or requiring higher level of care (inpatient or partial/intensive outpatient)
- (4) high risk pregnancies requiring transfer of care to Maternal-Fetal Medicine (e.g., maternal cancer, multiples, placenta accreta) and/or fetus known to have a severe congenital condition.
Where it is running
1 location listed across 1 US state.
- UPMC Magee Women's Hospital - Pittsburgh, Pennsylvania, United States